SCHEMBL3849036

SCHEMBL3849036

NCC1CCC(CNc2ncc3[nH]c(=O)n(Cc4cc(Cl)ccc4Cl)c3n2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 17/20 0.53
DCLK1 O15075 1/20 0.44
MAP4K4 O95819 1/20 0.44
CDK1 P06493 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
PIM1 P11309 1/20 0.44
CYP2C9 P11712 1/20 0.44
PRKACA P17612 1/20 0.44
CDK2 P24941 1/20 0.44
MATK P42679 1/20 0.44
FRK P42685 1/20 0.44
CSNK1D P48730 1/20 0.44
CLK2 P49760 1/20 0.44
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44
IRAK1 P51617 1/20 0.44
RPS6KA3 P51812 1/20 0.44
CDK5 Q00535 1/20 0.44
PRKCD Q05655 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13608105 1.00 PRKCQ (0.53) PRKCQDCLK1MAP4K4CDK1CYP3A4
SCHEMBL13608128 1.00 PRKCQ (0.53) PRKCQDCLK1MAP4K4CDK1CYP3A4
SCHEMBL13608144 0.93 PRKCQ (0.45) PRKCQDCLK1MAP4K4CDK1CYP3A4
SCHEMBL13608111 0.93 PRKCQ (0.45) PRKCQDCLK1MAP4K4CDK1CYP3A4
SCHEMBL13608107 0.93 PRKCQ (0.45) PRKCQDCLK1MAP4K4CDK1CYP3A4
SCHEMBL3846527 0.93 PRKCQ (0.45) PRKCQDCLK1MAP4K4CDK1CYP3A4
SCHEMBL13608114 0.91 PRKCQ (0.46) PRKCQDCLK1MAP4K4CDK1CYP3A4
SCHEMBL3855274 0.89 PRKCQ (0.41) PRKCQCDK2CSNK1DGSK3BHSP90AA1
SCHEMBL3844896 0.88 USP1 (0.40) PRKCQCDK2CSNK1DGSK3B
SCHEMBL3844899 0.88 USP1 (0.40) PRKCQCDK2CSNK1DGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281075-A1 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PHARMACOPEIA, INC. (US) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281075-A1 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PRKCE, PRKCZ, PRKCQ PRKCQ 3/4885DCLK1 1241/4885MAP4K4 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.